| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 175.962 | 168.953 | 186.224 | 156.110 | 202.227 | 180.902 | 303.439 | 242.074 | 162.332 | 118.226 |
| Total Income - EUR | 176.497 | 169.413 | 186.553 | 156.599 | 202.589 | 181.865 | 304.867 | 244.291 | 173.274 | 131.284 |
| Total Expenses - EUR | 152.394 | 142.383 | 160.401 | 138.779 | 155.483 | 151.104 | 204.141 | 168.279 | 128.745 | 102.691 |
| Gross Profit/Loss - EUR | 24.102 | 27.030 | 26.153 | 17.820 | 47.106 | 30.761 | 100.726 | 76.012 | 44.528 | 28.593 |
| Net Profit/Loss - EUR | 20.126 | 22.547 | 24.290 | 16.259 | 45.084 | 29.045 | 98.056 | 73.954 | 43.065 | 25.778 |
| Employees | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 |
Check the financial reports for the company - Orion Biologics Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.101 | 692 | 1.919 | 1.103 | 723 | 382 | 332 | 291 | 248 | 205 |
| Current Assets | 51.626 | 46.687 | 48.354 | 33.191 | 74.745 | 96.603 | 181.790 | 206.302 | 238.077 | 262.594 |
| Inventories | 424 | 9 | 991 | 973 | 954 | 3.352 | 3.853 | 3.865 | 6.608 | 3.088 |
| Receivables | 5.721 | 982 | 33.177 | 12.474 | 10.939 | 6.552 | 2.530 | 8.519 | 3.160 | 5.425 |
| Cash | 45.481 | 45.696 | 14.185 | 19.744 | 62.851 | 86.698 | 175.408 | 193.918 | 228.310 | 254.082 |
| Shareholders Funds | 31.996 | 34.295 | 35.851 | 27.814 | 61.485 | 78.408 | 163.606 | 184.705 | 227.210 | 251.718 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 20.732 | 13.094 | 14.424 | 6.496 | 14.070 | 18.685 | 18.586 | 21.981 | 11.173 | 11.162 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Orion Biologics Srl